Figure 5From: PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversityOverall predictive performance of of four pan-specific methods in identifying immunodominant CD4+ T-cell epitopes. Overall predictive performance of Predivac, NetMHCIIPan-2.0, TEPITOPEpan and MultiRTA in identifying immunodominant CD4+ T-cell epitopes is compared.Back to article page